NMT-cNP8 (Neomatrix Therapeutics)

N/A

Report date: 2025/06/11 10:26:11

Base Information

Drug NameNMT-cNP8 (Neomatrix Therapeutics)
Drug Alias NamePDGF targeting fibronectin peptide (NeoMatrix Therapeutics)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionPDGF modulators
TargetsUpdating
Therapy Area/IndicationsBurns
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeoMatrix Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeoMatrix Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsBurns
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A